Box Office: ‘Michael’ Soaring to Huge $12M-$13M in U.S. Previews Amid Over-the-Moon Audience Scores

The market is pricing this as more than a single-film beat; the real signal is that premium-format demand is still elastic for event content, and that matters most for IMAX’s revenue mix and utilization. A strong opening here should translate into outsized share capture because PLF screens monetize first-week enthusiasm better than standard auditoriums, so even a modest multiplier shortfall would still leave IMAX well positioned on near-term box office economics.

The second-order read-through is to exhibitors and content suppliers: if this title sustains momentum, studios will have more evidence that legacy IP with multigenerational awareness can still pull lapsed consumers back into theaters, improving the bargaining position of premium format operators and reducing the “theatrical is dead” narrative. That tends to help the whole moviegoing stack, but the incremental winner is whoever controls scarce premium inventory, not the underlying studio slate.

The bigger risk is front-loading. Strong previews plus polarizing reviews create a setup where opening-weekend prints look excellent but the back half of the run decays quickly if the core audience is exhausted by day one. If that happens, the stock reaction in IMAX can overshoot the eventual economics because the market will initially extrapolate a strong domestic start into a durable attendance reset that may not materialize.

On FOXA, the setup is much less direct despite the legacy association with the underlying IP history. This is mostly a sentiment read-through for broader media assets rather than a fundamentals catalyst, so any move there should be treated as a trading sympathy bid, not a durable rerating event.